These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 17035164)

  • 1. Comparison of intramuscular and intradermal applications of hepatitis B vaccine in hemodialysis patients.
    Karahocagil MK; Buzgan T; Irmak H; Karsen H; Akdeniz H; Akman N
    Ren Fail; 2006; 28(7):561-5. PubMed ID: 17035164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of intradermal hepatitis B vaccination compared to intramuscular vaccination in hemodialysis patients.
    Chanchairujira T; Chantaphakul N; Thanwandee T; Ong-Ajyooth L
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S33-40. PubMed ID: 17044452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of low dose intradermal hepatitis B vaccine: results of a randomized trial among health care workers.
    Das HS; Sawant P; Shirhatti RG; Vyas K; Vispute S; Dhadphale S; Patrawalla V; Desai N
    Trop Gastroenterol; 2002; 23(3):120-1. PubMed ID: 12693152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The evaluation of the effectiveness of multiple dose intradermal hepatitis B re-vaccination in hemodialyzed patients not responding to standard method of immunization.
    Radziszewski A; Gajda M; Pituch-Noworolska A; Drozdz M; Kraśniak A; Kaczmarczyk I; Hołyś S; Zurowski J; Sydor A; Sułowicz W
    Przegl Lek; 2007; 64(7-8):470-5. PubMed ID: 18409347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune response of intradermal hepatitis B vaccination at lower dose versus intramuscular vaccination at double standard dose in predialytic chronic renal failure patients.
    Somboonsilp W; Eiam-Ong S; Tungsanga K; Tirawatanapong T
    J Med Assoc Thai; 2003 Dec; 86(12):1122-7. PubMed ID: 14971519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose intradermal and subcutaneous versus intramuscular hepatitis B vaccination in primary non-responding hemodialysis patients.
    Sorkhi H; Dooki MR; Ebrahimnejad MS
    J Med Assoc Thai; 2006 Oct; 89(10):1648-53. PubMed ID: 17128839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of low dose intradermal hepatitis B vaccine and its comparison with standard dose intramuscular vaccination.
    Gomber S; Sharma R; Ramachandran VG
    Indian Pediatr; 2004 Sep; 41(9):922-6. PubMed ID: 15475635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The safety and efficacy of GM-CSF as an adjuvant in hepatitis B vaccination of chronic hemodialysis patients who have failed primary vaccination.
    Evans TG; Schiff M; Graves B; Agosti J; Barritt ML; Garner D; Holley JL
    Clin Nephrol; 2000 Aug; 54(2):138-42. PubMed ID: 10968690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low dose intradermal vaccination is superior to high dose intramuscular vaccination for hepatitis B in unresponsive hemodialysis patients.
    Micozkadioglu H; Zumrutdal A; Torun D; Sezer S; Ozdemir FN; Haberal M
    Ren Fail; 2007; 29(3):285-8. PubMed ID: 17497441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized comparison of intradermal and intramuscular vaccination against hepatitis B virus in incident chronic hemodialysis patients.
    Charest AF; McDougall J; Goldstein MB
    Am J Kidney Dis; 2000 Nov; 36(5):976-82. PubMed ID: 11054354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low response to intradermal hepatitis B vaccination in incident hemodialysis patients.
    Medeiros RH; Figueiredo AE; Poli-de-Figueiredo CE; d'Avila DO; de los Santos CA
    J Bras Nefrol; 2011 Mar; 33(1):45-9. PubMed ID: 21541462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of anti-HBV vaccine efficacy given intradermally and intramuscularly in hemodialysis patients].
    Miłkowski A; Wyrwicz G; Kubit P; Smoleński O
    Przegl Lek; 2000; 57(11):628-34. PubMed ID: 11293210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary high-dose intradermal hepatitis B vaccination in hemodialysis: cost-effectiveness evaluation at 2 years.
    Mat O; Mestrez F; Beauwens R; Muniz-Martinez MC; Dhaene M
    Hemodial Int; 2006 Jan; 10(1):49-55. PubMed ID: 16441827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomised controlled trial of intradermal hepatitis B vaccination and augmentation of response with erythropoietin.
    Anandh U; Thomas PP; Shastry JC; Jacob CK
    J Assoc Physicians India; 2000 Nov; 48(11):1061-3. PubMed ID: 11310381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative efficacy of two dosages of recombinant hepatitis B vaccine in healthy adolescents in India.
    Velu V; Nandakumar S; Shanmugam S; Shankar EM; Thangavel S; Kulkarni PS; Thyagarajan SP
    Pediatr Infect Dis J; 2007 Nov; 26(11):1038-41. PubMed ID: 17984812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative immunogenicity of 2 recombinant hepatitis B vaccines (GeneVac-B and Engerix-B) in adult patients with chronic renal failure.
    Rajapurkar MM; Gang S; Dabhi M; Kulkarni PS
    J Nephrol; 2007; 20(5):596-601. PubMed ID: 17918146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poor efficacy of intradermal administration of recombinant hepatitis B virus immunization in HIV-infected individuals who fail to respond to intramuscular administration of hepatitis B virus vaccine.
    Shafran SD; Mashinter LD; Lindemulder A; Taylor GD; Chiu I
    HIV Med; 2007 Jul; 8(5):295-9. PubMed ID: 17561875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B revaccination in healthy non-responder Chinese children: five-year follow-up of immune response and immunologic memory.
    Zhuang GH; Yan H; Wang XL; Hwang LY; Wu Q; Wang LR; Gao HY
    Vaccine; 2006 Mar; 24(12):2186-92. PubMed ID: 16310902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intradermal hepatitis B vaccination in workers not responsive to intramuscular vaccination].
    Bauer H; Potasman I; Pick N
    Harefuah; 1998 Mar; 134(6):441-4, 503. PubMed ID: 10909572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus vaccine in lymphoproliferative disorders: a prospective randomized study evaluating the efficacy of granulocyte-macrophage colony stimulating factor as a vaccine adjuvant.
    Yağci M; Acar K; Sucak GT; Yamaç K; Haznedar R
    Eur J Haematol; 2007 Oct; 79(4):292-6. PubMed ID: 17655695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.